This book provides clinical practitioners and the research community with detailed information on the diagnosis, prognosis, and treatment of non-Hodgkin lymphoma, taking into account the significant growth in knowledge including multiple therapeutic advances that have been achieved over the past 5-10 years. The work is subdivided into epidemiology, pathogenesis, pathology, imaging, and therapy of the non-Hodgkin lymphomas. The full range of therapeutic options are examined according to the major subtypes of non-Hodgkin lymphoma and the most up-to-date information is provided on current standard treatment options, including stem cell transplantation as well as new cutting-edge therapeutics.
Allogeneic Hematopoietic Cell Transplantation in Non-Hodgkins Lymphomas.- Management of Diffuse Large B-cell Lymphoma.- Epidemiology and Etiology of Non-Hodgkin Lymphoma.- Current Therapeutic Strategies and New Treatment Paradigms for Follicular Lymphoma.- Gene Expression Profiling in Non-Hodgkin lymphomas.- Management of the Marginal Zone Lymphomas.- Treatment Strategies in Mantle Cell Lymphoma.- Pathology of B-cell Lymphomas: Diagnosis and Biomarker Discovery.- Pathology of T-cell lymphomas: Diagnosis and Biomarker Discovery.- Imaging of non-Hodgkin lymphomas: Diagnosis and Response-Adapted Strategies.- Current Management of Peripheral T-cell lymphomas.- Post Transplant Lymphoproliferative Disorders.- Biology, Prognosis and Therapy of Waldenstr?m Macroglobulinemia.- Prognosis and Therapy of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma.
The text features a discussion of each characteristic feature of non-Hodgkins lymphoma & . The writing in the book is fluent and easy to read, with text that flows well even when dealing with complex arguments, enriched by explanatory images and tables. We can highly recommend this book, not only to experts, but to students and to all clinicians who have an interest in non-Hodgkins lymphoma. (Sara Pelllæ